Dr Philip Rosenthal

All Stories

Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4

Article • Hepatology Communications, October 2018, Wiley

Dr Philip Rosenthal
Placebo-Controlled Randomized Trial of an Intestinal Bile Salt Transport Inhibitor for Pruritus in Alagille Syndrome

Article • Hepatology Communications, September 2018, Wiley

Dr Philip Rosenthal
Editorial: an expert consensus for the management of chronic hepatitis B in Asian Americans

Article • Alimentary Pharmacology & Therapeutics, June 2018, Wiley

Dr Philip Rosenthal
Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection

Article • Hepatology, August 2017, Wiley

Dr Philip Rosenthal, WILLIAM BALISTRERI
Pediatric liver failure: we came, we saw, but have we conquered?

Article • F1000Research, August 2017, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Association between cytokines and liver histology in children with nonalcoholic fatty liver disease

Article • Hepatology Communications, July 2017, Wiley

Dr Philip Rosenthal
Hepatic steatosis after pediatric liver transplant

Article • Liver Transplantation, June 2017, Wiley

Dr Philip Rosenthal
The safety and effectiveness of ledipasvir−sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection

Article • Hepatology, June 2017, Wiley

Dr Philip Rosenthal, WILLIAM BALISTRERI
Shorter Leukocyte Telomere Length in Relation to Presumed Nonalcoholic Fatty Liver Disease in Mexican-American Men in NHANES 1999–2002

Article • International Journal of Hepatology, January 2017, Hindawi Publishing Corporation

Dr Philip Rosenthal
Under Utilization of Pancreas Transplants in Cystic Fibrosis Recipients in the United Network Organ Sharing (UNOS) Data 1987-2014

Article • American Journal of Transplantation, February 2016, Wiley

Dr Philip Rosenthal
Quality of Life and Its Determinants in a Multicenter Cohort of Children with Alagille Syndrome

Article • The Journal of Pediatrics, August 2015, Elsevier

Dr Philip Rosenthal
Faculty of 1000 evaluation for Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C Infected Patients with Compensated and Decompensated Cirrhosis.

Article • June 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Projections of the current and future disease burden of hepatitis C virus infection in malaysia.

Article • June 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for A Clinician's Guide to Drug-Drug Interactions with Direct Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection.

Article • June 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome.

Article • June 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for High hepatitis E virus seroprevalence with absence of chronic infection in HIV-infected patients.

Article • June 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Ursodeoxycholic Acid Inhibits Hepatic Cystogenesis in Experimental Models of Polycystic Liver Disease.

Article • June 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for The relationships between IFNL4 genotype, intrahepatic interferon-stimulated gene expression and interferon treatment response differs in HCV-1 compared with HCV-3.

Article • June 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Splenectomy attenuates murine liver fibrosis with hypersplenism stimulating hepatic accumulation of Ly-6C(lo) macrophages.

Article • June 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties.

Article • June 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Hepatitis B virus induces RNR-R2 expression via DNA damage response activation.

Article • June 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Ribavirin reduces absolute lymphocyte counts in hepatitis C virus infected patients treated with interferon-free direct-acting antiviral regimens.

Article • June 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Review article: the efficacy and safety of daclatasvir in the treatment of chronic hepatitis C virus infection.

Article • June 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection?

Article • June 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Is antenatal screening for hepatitis C virus cost effective? A decade's experience at a London centre.

Article • June 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Increased Pygo2 expression in liver of patients with hepatitis B virus related fibrosis.

Article • June 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for The accuracy and cost-effectiveness of hepatitis C core antigen assay in the monitoring of anti-viral therapy in patients with chronic hepatitis C genotype 4.

Article • June 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Hepatitis C Infection in the Elderly.

Article • June 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Transmission of Hepatitis C Virus among Prisoners, Australia, 2005-2012.

Article • May 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Chronic hepatitis C infection is associated with insulin resistance and lipid profiles.

Article • May 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy.

Article • May 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Comparison of Abbott RealTime HCV Genotype II with Versant Line Probe Assay 2.0 for Hepatitis C Virus Genotyping.

Article • May 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Direct-acting antiviral-based triple therapy on alpha-fetoprotein level in chronic hepatitis C patients.

Article • May 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Short and long-term effects of telaprevir on kidney function in patients with hepatitis C virus infection: a retrospective cohort study.

Article • May 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Genetic Variability of Hepatitis C Virus (HCV) 5' Untranslated Region in HIV/HCV Coinfected Patients Treated with Pegylated Interferon and Ribavirin.

Article • May 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Sofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestry.

Article • May 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Baseline prevalence and emergence of protease inhibitor resistance mutations following treatment in chronic HCV genotype 1-infected individuals.

Article • May 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Systematic review with meta-analysis: comparison between therapeutic regimens for paediatric chronic hepatitis C.

Article • May 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Factors Determining δ-Bilirubin Levels in Infants With Biliary Atresia

Article • Journal of Pediatric Gastroenterology and Nutrition, May 2015, Wolters Kluwer Health

Dr Philip Rosenthal
Faculty of 1000 evaluation for Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic HCV Genotype 1, 4, or 6 Infection: A Randomized Trial.

Article • April 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Interleukin-21 gene polymorphisms and chronic hepatitis B infection in a Chinese population.

Article • April 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Grazoprevir/Elbasvir plus Ribavirin For Chronic HCV Genotype-1 Infection After Failure of Combination Therapy Containing a Direct-Acting Antiviral Agent.

Article • April 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Control of temporal activation of hepatitis C virus-induced interferon response by domain 2 of nonstructural protein 5A.

Article • April 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Synthesis and Biological Evaluation of 4-Substituted Fluoronucleoside Analogs for the Treatment of Hepatitis B Virus Infection.

Article • April 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Circulating kidney injury molecule-1 predicts prognosis and poor outcome in patients with acetaminophen-induced liver injury.

Article • April 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Age as a Predictor of Significant Fibrosis Features in HBeAg-Negative Chronic Hepatitis B Virus Infection with Persistently Normal Alanine Aminotransferase.

Article • April 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for PTPN11/Shp2 Overexpression Enhances Liver Cancer Progression and Predicts Poor Prognosis of Patients.

Article • April 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Hepatic cell proliferation plays a pivotal role in the prognosis of alcoholic hepatitis.

Article • April 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection.

Article • April 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Comparison of once a day rifaximin to twice a day dosage in prevention of recurrence of hepatic encephalopathy in patients with chronic liver disease.

Article • April 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Spatiotemporal analysis of hepatitis C virus infection.

Article • April 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients.

Article • April 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Ombitasvir/Paritaprevir/r and Dasabuvir Plus Ribavirin in HCV Genotype 1-Infected Patients on Methadone or Buprenorphine.

Article • April 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for The Cost-Effectiveness of Sofosbuvir-Based Regimens for Treatment of Hepatitis C Virus Genotype 2 or 3 Infection.

Article • April 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Impairment of Type I but Not Type III IFN Signaling by Hepatitis C Virus Infection Influences Antiviral Responses in Primary Human Hepatocytes.

Article • April 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the optim study.

Article • April 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control.

Article • April 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for TM6SF2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients.

Article • April 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial.

Article • April 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Poor Sustained Virological Response in a Multicenter Real-Life Cohort of Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin plus Telaprevir or Boceprevir.

Article • April 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Immune Activation Response in Chronic HIV-Infected Patients: Influence of Hepatitis C Virus Coinfection.

Article • March 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Enhanced Functions of Peripheral γδ T Cells in Chronic Hepatitis B Infection during Interferon α Treatment In Vivo and In Vitro.

Article • March 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Non-cirrhotic thrombocytopenic patients with hepatitis C virus: characteristics and outcome of antiviral therapy.

Article • March 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Cost-effectiveness of novel regimens for the treatment of hepatitis C virus.

Article • March 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Genotype-specific differences in structural features of hepatitis C virus (HCV) p7 membrane protein.

Article • March 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for A Randomized Study Comparing Vitamin D3 and 1α (OH) D3 in Combination with Pegylated Interferon/Ribavirin Therapy for Chronic Hepatitis C.

Article • March 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Serum Interferon-Related MicroRNAs as Biomarkers to Predict the Response to Interferon Therapy in Chronic Hepatitis C Genotype 4.

Article • March 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir.

Article • March 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Low Levels of Microbial Translocation Marker LBP Are Associated with Sustained Viral Response after Anti-HCV Treatment in HIV-1/HCV Co-Infected Patients.

Article • March 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS).

Article • March 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Tenofovir rescue therapy in pregnant females with chronic hepatitis B.

Article • March 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Chronic hepatitis C virus infection and neurological and psychiatric disorders: An overview.

Article • March 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Hepatitis C virus-mediated Aurora B kinase inhibition modulates inflammatory pathway and viral infectivity.

Article • March 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.

Article • March 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Utility of Hepatitis C Viral Load Monitoring On Directly Acting Antiviral Therapy.

Article • March 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Screening for Zinc Deficiency in Patients with Cirrhosis: When Should We Start?

Article • March 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Is the Molecular Adsorbent Recirculating System the Answer for Children With Acute Liver Failure?

Article • Liver Transplantation, February 2015, Wiley

Dr Philip Rosenthal
Faculty of 1000 evaluation for Randomized trial of interferon- and ribavirin-free ombitasvir/paritaprevir/ritonavir in treatment-experienced hcv-infected patients.

Article • February 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for The inhibitory effects of anacardic Acid on hepatitis C virus life cycle.

Article • February 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Interferon lambda-3 polymorphism and response to pegylated interferon in patients with hepatitis D.

Article • February 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Cost-effectiveness of hepatitis C treatment for patients in early stages of liver disease.

Article • February 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients.

Article • February 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for S-phase arrest after vincristine treatment may promote hepatitis B virus replication.

Article • February 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Genetic Variants in Interleukin-28B Are Associated with Diabetes and Diabetes-Related Complications in Patients with Chronic Hepatitis C Virus Infection.

Article • February 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Risk Factors of HCC Development in Non-cirrhotic Patients with Sustained Virologic Response for Chronic HCV Infection.

Article • February 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Population Pharmacokinetic Modeling of Plasma and Intracellular Ribavirin Concentrations in Patients with Chronic Hepatitis C Virus.

Article • February 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study.

Article • February 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Baseline Analysis of a Young Alpha-1-AT Deficiency Liver Disease Cohort Reveals Frequent Portal Hypertension

Article • Journal of Pediatric Gastroenterology and Nutrition, February 2015, Wolters Kluwer Health

Dr Philip Rosenthal
Faculty of 1000 evaluation for Response-guided treatment of cirrhotic chronic hepatitis B patients: multicenter prospective study.

Article • January 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Successful anti-viral treatment improves survival of patients with advanced liver disease due to chronic hepatitis C.

Article • January 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Dynamical analysis on a chronic hepatitis C virus infection model with immune response.

Article • January 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Prevalence of abnormal glycometabolism in treatment-naive patients with hepatitis C virus infection in a Chinese Han population.

Article • January 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for STARTVerso4: faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV.

Article • January 2015, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Mechanisms of viral inactivation methods against hepatitis C virus.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Health care-associated hepatitis C virus infection.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Diagnostically untypable hepatitis C virus variants: It is time to resolve the problem.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Normocaloric low cholesterol diet modulates th17/treg balance in patients with chronic hepatitis C virus infection.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Efficacy and Safety of Faldaprevir, Deleobuvir, and Ribavirin in Treatment-naïve Patients with Chronic Hepatitis C and Advanced Liver Fibrosis/Cirrhosis.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Association of hepatitis C virus infection with incidence and progression of chronic kidney disease in a large cohort of US veterans.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Treatment of bile acid amidation defects with glycocholic acid

Article • Hepatology, December 2014, Wiley

Dr Philip Rosenthal
Faculty of 1000 evaluation for Exosome-associated hepatitis C virus in cell cultures and patient plasma.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for GB Virus C (GBV-C) Infection in Hepatitis C Virus (HCV) Seropositive Women with or at Risk for HIV Infection.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for A retrospective 15-year review: survival advantage after switching to sirolimus in hepatitis C virus infected liver graft recipients.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Intrahepatic and Peripheral CXCL10 Expression in HCV-infected Patients Treated with Telaprevir, Pegylated-Interferon and Ribavirin.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Baseline Interpatient Hepatitis B Viral Diversity Differentiates HBsAg Outcomes in Patients Treated With Tenofovir Disoproxil Fumarate.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for The genetics of hepatitis C virus underlie its ability to escape humoral immunity.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Applicability and efficacy of a model for prevention of perinatal transmission of hepatitis B virus infection: Single center study in Egypt.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Chronic Hepatitis B Virus Coinfection Is Associated With Renal Impairment Among Zambian HIV-Infected Adults.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for The Effects of Cytokines on Spontaneous Hepatitis B Surface Antigen Seroconversion in Chronic Hepatitis B Virus Infection.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for New treatments for chronic hepatitis C: An overview for paediatricians.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Management of chronic hepatitis B in severe liver disease.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for CD100 Up-Regulation Induced by Interferon-α on B Cells Is Related to Hepatitis C Virus Infection.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for MDA5 Plays a Critical Role in Interferon Response during Hepatitis C Virus Infection.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Ribavirin induced hemolysis: A novel mechanism of action against chronic hepatitis C virus infection.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for In silico single cell dynamics of hepatitis B virus infection and clearance.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Impact of IL28B genotype on first-week response to telaprevir-based therapy in HIV-HCV coinfection.

Article • December 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Long-Term Growth Outcomes in Children Treated for Chronic Hepatitis C

Article • The Journal of Pediatrics, December 2014, Elsevier

Dr Philip Rosenthal
Total Serum Bilirubin Predicts Fat-Soluble Vitamin Deficiency Better Than Serum Bile Acids in Infants With Biliary Atresia

Article • Journal of Pediatric Gastroenterology and Nutrition, December 2014, Wolters Kluwer Health

Dr Philip Rosenthal
Faculty of 1000 evaluation for Hepatitis C virus-mediated angiogenesis: molecular mechanisms and therapeutic strategies.

Article • November 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C.

Article • November 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Impact of treatment against Hepatitis C virus on the overall survival in naive patients with advanced liver disease.

Article • November 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Spontaneous and antiviral-induced cutaneous lesions in chronic hepatitis B virus infection.

Article • November 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors.

Article • November 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Advanced Hepatic Fibrosis and Steatosis Are Associated with Persistently Alanine Aminotransferase Elevation in Chronic Hepatitis C Patients Negative for HCV RNA During Pegylated Interferon Plus Ribavirin Therapy.

Article • November 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Bridging the data gaps in the epidemiology of hepatitis C virus infection in Malaysia using multi-parameter evidence synthesis.

Article • November 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Hepatic Decompensation Likely Attributable to Simeprevir in Patients with Advanced Cirrhosis.

Article • November 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Effect of spleen operation on antiviral treatment in hepatitis C virus-related cirrhotic patients.

Article • November 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Re-treatment of Chronic Hepatitis C Virus Genotype 1 Infection After Relapse: An Open-Label Pilot Study.

Article • November 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients.

Article • November 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3.

Article • November 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Liver Stiffness Measurement among Patients with Chronic Hepatitis B and C: Results from a 5-Year Prospective Study.

Article • November 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies.

Article • November 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Drug-drug interactions of telaprevir and boceprevir in HCV-monoinfected and HIV/HCV-coinfected patients can modify the adherence.

Article • November 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Rare detection of occult hepatitis B virus infection in children of mothers with positive hepatitis B surface antigen.

Article • November 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Hepatitis C virus infection as a traumatic experience.

Article • October 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Individualized treatment of genotype 1 naïve patients: an italian multicenter field practice experience.

Article • October 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Transcription of Hepatitis B Virus Covalently Closed Circular DNA Is Regulated by CpG Methylation during Chronic Infection.

Article • October 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Genotype F of hepatitis B: response to interferon.

Article • October 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Hepatitis A virus and the origins of picornaviruses.

Article • October 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Sofosbuvir with peginterferon-ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis.

Article • October 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Super-infection with woodchuck hepatitis virus (WHV) strain WHVNY of the livers chronically infected with the strain WHV7.

Article • October 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Incidence of natural resistance mutations in naïve chronic hepatitis B patients: a systematic review and meta-analysis.

Article • October 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for The serum IL-23 level predicts the response to pegylated interferon therapy in patients with chronic hepatitis B.

Article • October 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study.

Article • October 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Sofosbuvir-based treatment regimens for chronic, genotype 1 hepatitis C virus infection in u.s. Incarcerated populations: a cost-effectiveness analysis.

Article • October 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Daclatasvir plus Peginterferon and Ribavirin is Non-inferior to Peginterferon and Ribavirin Alone, and Reduces Duration of Treatment for HCV Genotype 2 or 3 Infection.

Article • October 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Delineating definitions and risk factors for metabolic syndrome after pediatric liver transplantation

Article • Liver Transplantation, September 2014, Wiley

Dr Philip Rosenthal
Faculty of 1000 evaluation for Transmembrane serine protease TMPRSS2 activates hepatitis C virus infection.

Article • September 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Acute HIV infection is beneficial for controlling chronic hepatitis B.

Article • September 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Response-guided Boceprevir-based Triple-Therapy in HIV/HCV-coinfected Patients: The HIVCOBOC-RGT Study.

Article • September 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Chronic Hepatitis B Virus Infection in Children And Adolescents in Japan: A Single-Center 30-Year Study.

Article • September 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Safety Profile of Boceprevir and Telaprevir in Chronic Hepatitis C: Real-World Experience From HCV-TARGET.

Article • September 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatment.

Article • September 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic HCV, genotype-1 infected patients.

Article • September 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for What is the impact of a country-wide scale-up in antiviral therapy on the characteristics and sustained viral response rates of patients treated for hepatitis C?

Article • September 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Medical Status of 219 Children with Biliary Atresia Surviving Long-Term with Their Native Livers: Results from a North American Multicenter Consortium

Article • The Journal of Pediatrics, September 2014, Elsevier

Dr Philip Rosenthal
Faculty of 1000 evaluation for Global epidemiology and genotype distribution of the hepatitis C virus infection.

Article • August 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Effect of prolonged administration of pegylated interferon/ribavirin therapy in genotypes 2a and 2b: Propensity score-matched analysis.

Article • August 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Prediction of treatment week eight response & sustained virologic response in patients treated with boceprevir plus peginterferon alfa and ribavirin.

Article • August 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Effect of Peginterferon alfa-2b and Ribavirin on Hepatocellular Carcinoma Prevention in Older Patients with Chronic Hepatitis C.

Article • August 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomis...

Article • August 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Cytokinome profile evaluation in patients with hepatitis C virus infection.

Article • July 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection.

Article • July 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for A Randomized Phase 2b Study of Peginterferon Lambda-1a for the Treatment of Chronic HCV Infection.

Article • July 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Targeting Apoptosis in Autoimmune Hepatitis.

Article • July 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Burden of HIV and hepatitis C co-infection: the changing epidemiology of hepatitis C in HIV-infected patients in France.

Article • July 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections.

Article • July 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Randomized trial of asunaprevir plus peginterferon alfa and ribavirin for previously untreated genotype 1 or 4 chronic hepatitis C.

Article • July 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon-naïve patients with HIV/HCV genotype 2/3 co-infection in Italy.

Article • July 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest) and elastography (FibroScan).

Article • July 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Antiviral treatment of hepatitis C.

Article • July 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Innate immune cell networking in hepatitis C virus infection.

Article • July 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis.

Article • July 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Association of interleukin 28B polymorphism and mutations in the NS5A region of hepatitis C virus genotype 2 with interferon responsiveness.

Article • July 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Low Serum Vitamin D Levels Are Associated with Severe Histological Features and Poor Response to Therapy in Patients with Autoimmune Hepatitis.

Article • July 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for T cell immunity and HCV reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen.

Article • July 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Impaired IFN signaling in chronic hepatitis C patients with advanced fibrosis via the TGF-β signaling pathway.

Article • July 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir and Peg-IFN during triple therapy in treatment-experienced HCV infected cirrhotic patients (ANRS CO20-CUPIC).

Article • July 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Efficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: a meta-analysis.

Article • July 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.

Article • July 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Another Explanation for Breast Milk Jaundice

Article • The Journal of Pediatrics, July 2014, Elsevier

Dr Philip Rosenthal
Faculty of 1000 evaluation for Non-invasive fibrosis assessment predicts sustained virological response to telaprevir with pegylated interferon and ribavirin for chronic hepatitis C.

Article • June 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Occasional spontaneous clearance of chronic hepatitis C virus in HIV infected individuals.

Article • June 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Sustained Virological Response with Telaprevir in 1078 Patients With Advanced Hepatitis C: The International Telaprevir Access Program.

Article • June 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for HCV RNA assay sensitivity impacts the management of patients treated with direct-acting antivirals.

Article • June 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for High-resolution quantification of hepatitis C virus genome-wide mutation load and its correlation with the outcome of peginterferon-alpha2a and ribavirin combination therapy.

Article • June 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for CD8(+) T-Cell Responses in Acute Hepatitis C Virus Infection.

Article • June 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Ficolin-2 Inhibits Hepatitis C Virus Infection, whereas Apolipoprotein E3 Mediates Viral Immune Escape.

Article • June 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Coinfection with HIV-1 Alleviates Iron Accumulation in Patients with Chronic Hepatitis C Virus Infection.

Article • June 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for The Expression of the Hepatocyte SLAMF3 (CD229) Receptor Enhances the Hepatitis C Virus Infection.

Article • June 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Peginterferon alfa-2a is associated with elevations in alanine aminotransferase at the end of treatment in chronic hepatitis C patients with sustained virologic response.

Article • June 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for IP-10 Kinetics in Treatment-Naïve Versus -Experienced Patients Receiving Interferon-Free Hepatitis C Virus Therapy: Implications for the Innate Immune Response.

Article • June 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Apolipoprotein H expression is associated with IL28B genotype and viral clearance in Hepatitis C virus infection.

Article • June 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Declining Incidence of Hepatitis C Virus Infection among People Who Inject Drugs in a Canadian Setting, 1996-2012.

Article • June 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial.

Article • June 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial.

Article • June 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Chronic HCV Infection Affects Cardiac Mass in Normotensives.

Article • June 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver-prognosis in chronic hepatitis C.

Article • June 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies.

Article • June 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3.

Article • June 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study.

Article • June 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Response-Guided Therapy for Hepatitis C Genotype 2 and 3 in Those with HIV Coinfection.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Response-Guided Therapy in Patients with Genotype 1 HCV: Current Status and Future Prospects.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Bridging Basic Science and Clinical Research - The EASL Monothematic Conference on Translational Research in Viral Hepatitis.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Protection against hepatitis C infection via NK cells in highly-exposed uninfected injecting drug users.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Cytopenias during treatment of HIV-HCV-coinfection with pegylated interferon and ribavirin: safety analysis of the OPERA study.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Hepatic Steatosis Is Highly Prevalent in Hepatitis B Patients and Negatively Associated with Virological Factors.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Emergent properties of the interferon-signalling network may underlie the success of hepatitis C treatment.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Increased uptake and new therapies are needed to avert rising hepatitis C-related end stage liver disease in England: modelling the predicted impact of treatment under different scenarios.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Long-term therapy of chronic delta hepatitis with peginterferon alfa.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Statins and Hepatitis C Virus Infection: An Old Therapy With New Scope.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Mericitabine and ritonavir-boosted danoprevir with or without ribavirin in treatment-naive HCV genotype 1 patients: INFORM-SVR study.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Involvement of MAP3K8 and miR-17-5p in Poor Virologic Response to Interferon-Based Combination Therapy for Chronic Hepatitis C.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-experienced Patients with HCV Genotype 1b Infection.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Effect of thrombocytopenia on treatment tolerability and outcome in patients with chronic HCV infection and advanced hepatic fibrosis.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Next generation sequencing sheds light on the natural history of hepatitis C infection in patients that fail treatment.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Use of Corticosteroids After Hepatoportoenterostomy for Bile Drainage in Infants With Biliary Atresia

Article • JAMA, May 2014, American Medical Association (AMA)

Dr Philip Rosenthal
Faculty of 1000 evaluation for Limited Utility of ITPA Deficiency to Predict Early Anemia in HCV Patients with Advanced Fibrosis Receiving Telaprevir.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Review article: 2014 UK consensus guidelines - hepatitis C management and direct-acting anti-viral therapy.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Cirrhosis Regression in Hepatitis C Patients with Sustained Virologic Response after Anti-Viral therapy: A Meta-analysis.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection.

Article • May 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Tu1838 Hepatic Steatosis in Pediatric Liver Transplant Recipients: Single-Center Review of Post-Transplant Liver Biopsies

Article • Gastroenterology, May 2014, Elsevier

Dr Philip Rosenthal
Su1004 Drug Resistance, Basal Core Promoter and Pre-Core Stop Mutations in a Large Cohort of North American Children With Hepatitis B: Results for the Pediatric Cohort Study of the NIDDK-Sponsored Hepatitis B Research Network (HBRN)

Article • Gastroenterology, May 2014, Elsevier

Dr Philip Rosenthal
Faculty of 1000 evaluation for The Rapid Evolution of Treatment Strategies for Hepatitis C.

Article • April 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Therapy for hepatitis C--the costs of success.

Article • April 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Patient-Reported Outcomes Assessment in Chronic Hepatitis C Treated with Sofosbuvir and Ribavirin: The VALENCE Study.

Article • April 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Simeprevir with Peginterferon/Ribavirin for Treatment-Naïve Hepatitis C Genotype 1 Patients in Japan: CONCERTO-1, a Phase III Trial.

Article • April 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for The Combination of MK-5172, Peginterferon, and Ribavirin is Effective in Treatment-Naive Patients with Hepatitis C Virus Genotype 1 Infection Without Cirrhosis.

Article • April 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Selective inhibition of hepatitis C virus infection by hydroxyzine and benztropin.

Article • April 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens.

Article • April 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for SILEN-C3: A Phase 2 Randomized Trial with Faldaprevir plus PegIFN/Ribavirin in Treatment-naive HCV Genotype-1-infected Patients.

Article • April 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Effectiveness of Telaprevir or Boceprevir in Treatment-experienced Patients with HCV Genotype 1 Infection and Cirrhosis.

Article • April 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Regulatory Phenotype, PD-1 and TLR3 Expression in T Cells and Monocytes from HCV Patients Undergoing Antiviral Therapy: A Randomized Clinical Trial.

Article • April 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 HCV in interferon ineligible/intolerant individuals.

Article • April 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Reduction of microRNA-122 expression in IFNL3 CT+TT carriers and during progression of fibrosis in patients with chronic hepatitis C.

Article • April 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: A randomized, controlled study.

Article • April 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Interobserver Variability in Transient Elastography Analysis of Patients with Chronic Hepatitis C.

Article • April 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Elderly age is not a negative predictive factor for virological response to therapy with pegylated interferon-α and ribavirin in chronic hepatitis C virus patients.

Article • April 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Review article: HCV genotype 3 - the new treatment challenge.

Article • March 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Asymmetric dimethylarginine responses during interferon-α-induced depression in patients with chronic hepatitis C infection.

Article • March 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication.

Article • March 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Schistosomiasis does not affect the outcome of HCV infection in genotype 4-infected patients.

Article • March 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Reduced Toll-like receptor-9 expression on peripheral CD14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy.

Article • March 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection.

Article • March 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Effects of Polymorphisms in Ifnl3 (Il28b) on Sustained Virologic Response to Therapy in Patients with Chronic Hepatitis D Virus Infection.

Article • March 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C.

Article • March 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C.

Article • March 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Risk Factors for Hepatitis C Transmission in HIV Patients, Hepacam Study, ANRS 12267 Cambodia.

Article • March 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Adjuvant Radiotherapy in Centrally Located Hepatocellular Carcinomas after Hepatectomy with Narrow Margin (<1 cm): A Prospective Randomized Study.

Article • March 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Novel Spiroketal Pyrrolidine GSK2336805 Potently Inhibits Key Hepatitis C Virus Genotype 1b Mutants: From Lead to Clinical Compound.

Article • March 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders.

Article • March 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Relationship Between Alcohol Use Categories and Noninvasive Markers of Advanced Hepatic Fibrosis in HIV-Infected, Chronic Hepatitis C Virus-Infected, and Uninfected Patients.

Article • March 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Radiofrequency Ablation of Hepatocellular Carcinoma as First-Line Treatment: Long-term Results and Prognostic Factors in 162 Patients with Cirrhosis.

Article • March 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Virological predictors of response to retreatment in hepatitis C genotype 2 infected patients.

Article • February 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Review article: the treatment of genotype 1 chronic hepatitis C virus infection in liver transplant candidates and recipients.

Article • February 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Health-related quality of life in genotype 1 treatment-naïve chronic hepatitis C patients receiving telaprevir combination treatment in the ADVANCE study.

Article • February 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial.

Article • February 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin.

Article • February 2014, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Porphyria

Article • January 2014, Elsevier

Dr Philip Rosenthal
Faculty of 1000 evaluation for Does intravenous fish oil benefit patients post-surgery? A meta-analysis of randomised controlled trials.

Article • December 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for A prospective randomized controlled trial of hemostasis with a bipolar sealer during hepatic transection for liver resection.

Article • December 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial.

Article • December 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Effect and safety of interferon for hepatocellular carcinoma: a systematic review and meta-analysis.

Article • December 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for A Phase II Study of Cixutumumab (IMC-A12, NSC742460) in Advanced Hepatocellular Carcinoma.

Article • December 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Phase II Trial of Palliative Radiotherapy for Hepatocellular Carcinoma and Liver Metastases.

Article • December 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.

Article • December 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Pediatric liver transplantation for urea cycle disorders and organic acidemias: United Network for Organ Sharing data for 2002-2012

Article • Liver Transplantation, November 2013, Wiley

Dr Philip Rosenthal
Faculty of 1000 evaluation for Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.

Article • November 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Metronomic Capecitabine in Advanced Hepatocellular Carcinoma Patients: A Phase II Study.

Article • November 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Meta-analysis of ischaemic preconditioning for liver resections.

Article • November 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Radiofrequency-assisted versus clamp-crushing parenchyma transection in cirrhotic patients with hepatocellular carcinoma: a randomized clinical trial.

Article • November 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Microwave coagulation for liver metastases.

Article • November 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis.

Article • November 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Unresectable Hepatocellular Carcinoma: Randomized Controlled Trial of Transarterial Ethanol Ablation versus Transcatheter Arterial Chemoembolization.

Article • November 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Liver in Systemic Disease

Article • November 2013, Springer Science + Business Media

Dr Philip Rosenthal
F1000Prime recommendation of Raltegravir pharmacokinetics in HIV/HCV-coinfected patients with advanced liver cirrhosis (Child-Pugh C).

Article • November 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial.

Article • November 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Health Related Quality of Life in Patients with Biliary Atresia Surviving with their Native Liver

Article • The Journal of Pediatrics, October 2013, Elsevier

Dr Philip Rosenthal
Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: A retrospective study

Article • Hepatology, September 2013, Wiley

Dr Philip Rosenthal
Extrahepatic Anomalies in Infants With Biliary Atresia: Results of a Large Prospective North American Multicenter Study

Article • Hepatology, September 2013, Wiley

Dr Philip Rosenthal
Faculty of 1000 evaluation for Faldaprevir and deleobuvir for HCV genotype 1 infection.

Article • September 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Herbal medicines for fatty liver diseases.

Article • September 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Phase I Study Investigating Everolimus Combined With Sorafenib in Patients With Advanced Hepatocellular Carcinoma.

Article • September 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for CF102 for the treatment of hepatocellular carcinoma: a phase I/II, open-label, dose-escalation study.

Article • September 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study.

Article • September 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia.

Article • September 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis.

Article • September 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study.

Article • September 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy.

Article • August 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Budesonide versus Prednisone with Azathioprine for the Treatment of Autoimmune Hepatitis in Children and Adolescents.

Article • August 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Randomized Controlled Trial of Danoprevir Plus Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Patients with HCV Genotype 1 Infection.

Article • August 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-Naïve genotype 1 hepatitis C: The randomized PILLAR study.

Article • August 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for A Randomized, Double-Blind, Controlled Trial Comparing Rifaximin Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy.

Article • August 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: A randomized double-blind study.

Article • August 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Transarterial chemoembolization in combination with local therapies for hepatocellular carcinoma: a meta-analysis.

Article • August 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Directly observed pegylated interferon plus self-administered ribavirin for the treatment of hepatitis C virus infection in people actively using drugs: a randomized controlled trial.

Article • August 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B

Article • Journal of Clinical Investigation, August 2013, American Society for Clinical Investigation

Dr Philip Rosenthal
Faculty of 1000 evaluation for Interventions for treating cholestasis in pregnancy.

Article • July 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Cryotherapy for liver metastases.

Article • July 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Percutaneous ethanol injection for liver metastases.

Article • July 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Electro-coagulation for liver metastases.

Article • July 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Selecting Patients for Acute Normovolemic Hemodilution during Hepatic Resection: A Prospective Randomized Evaluation of Nomogram-Based Allocation.

Article • July 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography - a randomised study.

Article • July 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Telaprevir Activity in Treatment-Naive Genotype 4 Hepatitis C-Infected Patients: A Randomized Trial.

Article • July 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial.

Article • July 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Anticoagulation in cirrhosis: Ready…. Set…. Wait!

Article • June 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for A randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis.

Article • June 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Evaluation of postoperative antibiotic prophylaxis after liver resection: a randomized controlled trial.

Article • June 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases.

Article • June 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study.

Article • June 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Randomized clinical trial on enhanced recovery versus standard care following open liver resection.

Article • June 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for CT with hepatic arterioportography as a pretreatment examination for hepatocellular carcinoma patients: a randomized controlled trial.

Article • June 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization.

Article • June 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
F1000Prime recommendation of Systematic review: Asian patients with chronic hepatitis C infection.

Article • May 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
F1000Prime recommendation of Meta-analysis: pegylated interferon α-2a achieves higher early virological responses than α-2b in chronic hepatitis C.

Article • May 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
F1000Prime recommendation of Telbivudine versus entecavir for nucleos(t)ide-naive HBeAg-positive chronic hepatitis B: a meta-analysis.

Article • May 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
F1000Prime recommendation of Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases.

Article • May 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
F1000Prime recommendation of Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results.

Article • May 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
F1000Prime recommendation of Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options.

Article • May 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
F1000Prime recommendation of Management of the extrahepatic symptoms of chronic hepatitis C: feasibility of a randomized controlled trial of exercise.

Article • May 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
F1000Prime recommendation of A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma.

Article • May 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
F1000Prime recommendation of Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial.

Article • May 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Genetic Defects in Bile Acid Conjugation Cause Fat-Soluble Vitamin Deficiency

Article • Gastroenterology, May 2013, Elsevier

Dr Philip Rosenthal
Faculty of 1000 evaluation for Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis.

Article • April 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for The Mediterranean Diet Improves Hepatic Steatosis and Insulin Sensitivity in Individuals with Nonalcoholic Fatty Liver Disease.

Article • April 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with NAFLD (The RAED2 randomized trial).

Article • April 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Everolimus does not further reduce polycystic liver volume when added to long acting octreotide Results from a randomized controlled trial.

Article • April 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
F1000Prime recommendation of Adjuvant iodine-125 brachytherapy for hepatocellular carcinoma after complete hepatectomy: a randomized controlled trial.

Article • April 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
F1000Prime recommendation of Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates.

Article • April 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
F1000Prime recommendation of Antibody persistence and booster vaccination of a fully liquid hexavalent vaccine coadministered with measles/mumps/rubella and varicella vaccines at 15-18 months of age in healthy South African infants.

Article • April 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Patterns of Interferon-alpha Induced Thyroid Dysfunction Vary with Ethnicity, Sex, Smoking Status and Pre-Treatment TSH in an International Cohort of Patients Treated for Hepatitis C.

Article • April 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Meta-analysis: oral or enteral nutritional supplementation in cirrhosis.

Article • March 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.

Article • March 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Midodrine and Clonidine in Patients With Cirrhosis and Refractory or Recurrent Ascites: A Randomized Pilot Study.

Article • March 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients.

Article • March 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for 52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B.

Article • March 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Frequency of Thyroid Dysfunctions during Interferon Alpha Treatment of Single and Combination Therapy in Hepatitis C Virus-Infected Patients: A Systematic Review Based Analysis.

Article • March 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Autoantibodies and Autoimmune Disease During Treatment of Children With Chronic Hepatitis C

Article • Journal of Pediatric Gastroenterology and Nutrition, March 2013, Wolters Kluwer Health

Dr Philip Rosenthal
F1000Prime recommendation of Exploratory study of oral combination antiviral therapy for hepatitis C.

Article • February 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C.

Article • February 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for JUMP-C: A randomized trial of mericitabine plus peginterferon alfa-2a/ribavirin for 24 weeks in treatment-naive HCV genotype 1/4 patients.

Article • February 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Timing of hepatectomy in resectable synchronous colorectal liver metastases (SCRLM): Simultaneous or delayed?

Article • February 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for PROPEL: A randomized trial of mericitabine plus peginterferon alfa-2a/ribavirin therapy in treatment-naive HCV genotype 1/4 patients.

Article • February 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Automated low flow pump system for the treatment of refractory ascites: A multi-center safety and efficacy study.

Article • February 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Meta-analysis: the diagnostic accuracy of critical flicker frequency in minimal hepatic encephalopathy.

Article • February 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Efficacy and tolerability of telaprevir for chronic hepatitis virus C genotype 1 infection: A meta-analysis.

Article • February 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Randomized clinical trial of the impact of insulin therapy on liver function in patients undergoing major liver resection.

Article • February 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial.

Article • February 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Lack of HLA predominance and HLA shared epitopes in biliary Atresia

Article • SpringerPlus, February 2013, Springer Science + Business Media

Dr Philip Rosenthal
Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: A placebo-controlled clinical trial

Article • Hepatology, February 2013, Wiley

Dr Philip Rosenthal
Faculty of 1000 evaluation for Ursodeoxycholic acid for primary biliary cirrhosis.

Article • January 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: The RELIEF trial.

Article • January 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir.

Article • January 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Effect of Antithrombin, Protein C and Protein S on Portal Vein Thrombosis in Liver Cirrhosis: A Meta-Analysis.

Article • January 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Mathematical Modeling of Triphasic Viral Dynamics in Patients with HBeAg-Positive Chronic Hepatitis B Showing Response to 24-Week Clevudine Therapy.

Article • January 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Screening for hepatitis C virus infection in adults: a systematic review for the U.S. Preventive Services Task Force.

Article • January 2013, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for High Genetic Barrier Nucleos(t)ide Analogue(s) for Prophylaxis From Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review.

Article • December 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Pharmacogenetics of Efficacy and Safety of HCV Treatment in HCV-HIV Coinfected Patients: Significant Associations with IL28B and SOCS3 Gene Variants.

Article • December 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Improved Inflammatory Activity With Peginterferon Alfa-2b Maintenance Therapy in Non-cirrhotic Prior Nonresponders: a Randomized Study.

Article • December 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Another drug in the armamentarium to combat hepatitis B virus in adolescents

Article • Hepatology, December 2012, Wiley

Dr Philip Rosenthal
Faculty of 1000 evaluation for Test of IL28B Polymorphisms in Chronic Hepatitis C Patients Treated with PegIFN and Ribavirin Depends on HCV Genotypes: Results from a Meta-Analysis.

Article • November 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Meta-analysis of laparoscopic versus open cholecystectomy for patients with liver cirrhosis and symptomatic cholecystolithiasis.

Article • November 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Excess body mass index and risk of liver cancer: a nonlinear dose-response meta-analysis of prospective studies.

Article • November 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis.

Article • November 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review.

Article • November 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.

Article • November 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria.

Article • November 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Radiofrequency Ablation versus Resection for Colorectal Cancer Liver Metastases: A Meta-Analysis.

Article • November 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Zoledronic Acid Versus Alendronate for the Prevention of Bone Loss after Heart or Liver Transplantation.

Article • November 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for A Meta-Analysis of Nucleos(t)ide Analogues in Patients with Decompensated Cirrhosis Due to Hepatitis B.

Article • November 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Portal Hypertension in Children and Young Adults With Biliary Atresia

Article • Journal of Pediatric Gastroenterology and Nutrition, November 2012, Wolters Kluwer Health

Dr Philip Rosenthal
Faculty of 1000 evaluation for Chlorambucil for patients with primary biliary cirrhosis.

Article • October 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Pre-operative biliary drainage for obstructive jaundice.

Article • October 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases.

Article • October 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases.

Article • October 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs.

Article • October 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Body Mass Index and Risk of Primary Liver Cancer: A Meta-Analysis of Prospective Studies.

Article • October 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Antifibrinolytic amino acids for upper gastrointestinal bleeding in patients with acute or chronic liver disease.

Article • October 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Use of Early-TIPS for High-Risk Variceal Bleeding. Results of a post-RCT Surveillance Study.

Article • October 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for A comparison of intra-operative blood loss and acid-base balance between vasopressor and inotrope strategy during living donor liver transplantation: a randomised, controlled study.

Article • October 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial.

Article • October 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Yttrium(90) radioembolization for intermediate-advanced hepatocarcinoma: A phase II study.

Article • September 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Nutritional interventions for liver-transplanted patients.

Article • September 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study.

Article • September 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B.

Article • September 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial.

Article • September 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia.

Article • September 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis.

Article • September 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Interferon-α for patients with chronic hepatitis delta: a systematic review of randomized clinical trials.

Article • September 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consorti...

Article • September 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Posttransplant metabolic syndrome in children and adolescents after liver transplantation: A systematic review

Article • Liver Transplantation, August 2012, Wiley

Dr Philip Rosenthal
Faculty of 1000 evaluation for Dose-response relationship of phototherapy for hyperbilirubinemia.

Article • August 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Case definitions for acute hepatitis C virus infection: a systematic review.

Article • August 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for The Combination of Octreotide and Midodrine Is Not Superior to Albumin in Preventing Recurrence of Ascites After Large-Volume Paracentesis.

Article • August 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial.

Article • August 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Postprandial effects of dark chocolate on portal hypertension in patients with cirrhosis: results of a phase 2, double-blind, randomized controlled trial.

Article • August 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis.

Article • August 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis c after liver transplantation.

Article • August 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Randomized clinical trial of open hepatectomy with or without intermittent Pringle manoeuvre.

Article • August 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study.

Article • August 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Calcineurin inhibitor sparing with mycophenolate mofetil in liver transplantion: a systematic review of randomized controlled trials.

Article • August 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Living donor vs. deceased donor liver transplantation for patients with hepatitis C virus-related diseases.

Article • August 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Hyperbilirubinemia, augmentation of endothelial function, and decrease in oxidative stress in Gilbert syndrome.

Article • August 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Pegylated interferon for chronic hepatitis C in children affects growth and body composition: Results from the pediatric study of hepatitis C (PEDS-C) trial

Article • Hepatology, August 2012, Wolters Kluwer Health

Dr Philip Rosenthal
Impact of the donor body mass index on the survival of pediatric liver transplant recipients and Post-transplant obesity

Article • Liver Transplantation, July 2012, Wiley

Dr Philip Rosenthal
Faculty of 1000 evaluation for Liver and skin histopathology in adults with acid sphingomyelinase deficiency (Niemann-Pick disease type B).

Article • June 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization.

Article • June 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Factors That Predict Response of Patients With Hepatitis C Virus Infection to Boceprevir.

Article • June 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Rapid point-of-care first-line screening tests for hepatitis B infection: a meta-analysis of diagnostic accuracy (1980-2010).

Article • June 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-α and ribavirin.

Article • June 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Hypothermic machine preservation reduces molecular markers of ischemia/reperfusion injury in human liver transplantation.

Article • June 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Treatment of Recurrent HCV Infection Following Liver Transplantation: Results of a Multicenter, Randomized, versus placebo, Trial of ribavirin alone as maintenance therapy after one year of Peginterferon Alfa-2A plus Riba...

Article • June 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study.

Article • June 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Faculty of 1000 evaluation for Immunogenicity and Safety of Two Tetravalent (Measles, Mumps, Rubella, Varicella) Vaccines Co-Administered with Hepatitis A and Pneumococcal Conjugate Vaccines to Children 12 14 Months of Age.

Article • June 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
NASPGHAN Practice Guidelines

Article • Journal of Pediatric Gastroenterology and Nutrition, June 2012, Wolters Kluwer Health

Dr Philip Rosenthal
When Should We Perform TIPS in Children?

Article • Journal of Pediatric Gastroenterology and Nutrition, May 2012, Wolters Kluwer Health

Dr Philip Rosenthal
Validation and Modification of Simplified Diagnostic Criteria for Autoimmune Hepatitis in Children

Article • Clinical Gastroenterology and Hepatology, April 2012, Elsevier

Dr Philip Rosenthal
Fetal Outcomes in Pregnancies Complicated by Intrahepatic Cholestasis of Pregnancy in a Northern California Cohort

Article • PLoS ONE, March 2012, PLOS

Dr Philip Rosenthal
Auxiliary Liver Transplantation for Amanita phalloides Poisoning

Article • Journal of Pediatric Gastroenterology and Nutrition, March 2012, Wolters Kluwer Health

Dr Philip Rosenthal
Faculty of 1000 evaluation for Patients with biliary atresia have elevated direct/conjugated bilirubin levels shortly after birth.

Article • February 2012, Faculty of 1000, Ltd.

Dr Philip Rosenthal
Complete Immunosuppression Withdrawal and Subsequent Allograft Function Among Pediatric Recipients of Parental Living Donor Liver Transplants

Article • JAMA, January 2012, American Medical Association (AMA)

Professor Sandy Feng, Dr Philip Rosenthal
Correlation of Vitamin E, Uric Acid, and Diet Composition With Histologic Features of Pediatric NAFLD

Article • Journal of Pediatric Gastroenterology and Nutrition, January 2012, Wolters Kluwer Health

Dr Philip Rosenthal
Overweight and obesity in pediatric liver transplant recipients: Prevalence and predictors before and after transplant, United Network for Organ Sharing Data, 1987-2010

Article • Pediatric Transplantation, November 2011, Wiley

Dr Philip Rosenthal
Morphologic Findings in Progressive Familial Intrahepatic Cholestasis 2 (PFIC2)

Article • The American Journal of Surgical Pathology, May 2011, Wolters Kluwer Health

Dr Philip Rosenthal
Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in children

Article • Hepatology, April 2011, Wiley

Dr Philip Rosenthal
Interpreting Conjugated Bilirubin Levels in Newborns

Article • The Journal of Pediatrics, April 2011, Elsevier

Dr Philip Rosenthal
Pseudo Gallbladder sign in biliary atresia—an imaging pitfall

Article • Pediatric Radiology, March 2011, Springer Science + Business Media

Dr Philip Rosenthal
The Combination of Ribavirin and Peginterferon Is Superior to Peginterferon and Placebo for Children and Adolescents With Chronic Hepatitis C

Article • Gastroenterology, February 2011, Elsevier

Dr Philip Rosenthal
Management of Portal Hypertension in Children

Article • Current Gastroenterology Reports, October 2010, Springer Science + Business Media

Dr Philip Rosenthal
Treatment of children with chronic hepatitis B virus infection in the United States: Patient selection and therapeutic options

Article • Hepatology, October 2010, Wiley

Dr Philip Rosenthal
Ophthalmologic Complications in Children With Chronic Hepatitis C Treated With Pegylated Interferon

Article • Journal of Pediatric Gastroenterology and Nutrition, August 2010, Wolters Kluwer Health

Dr Philip Rosenthal
Differences in presentation and progression between severe FIC1 and BSEP deficiencies

Article • Journal of Hepatology, July 2010, Elsevier

Dr Philip Rosenthal
Association Between Metabolic Syndrome and Liver Histology Among Children With Nonalcoholic Fatty Liver Disease

Article • The American Journal of Gastroenterology, April 2010, Wolters Kluwer Health

Dr Philip Rosenthal
Skepticism to vaccines: enough already?

Article • Pediatric Health, April 2010, Future Medicine

Dr Philip Rosenthal
Hepatitis A in Children

Article • January 2010, Springer Science + Business Media

Dr Philip Rosenthal
Treatment of nonalcoholic fatty liver disease in children: TONIC trial design

Article • Contemporary Clinical Trials, January 2010, Elsevier

Dr Philip Rosenthal
T1129 Clinical Course of Pediatric Patients with Primary Sclerosing Cholangitis

Article • Gastroenterology, May 2009, Elsevier

Dr Philip Rosenthal
Nontransplant surgical interventions in progressive familial intrahepatic cholestasis

Article • Journal of Pediatric Surgery, April 2009, Elsevier

Dr Philip Rosenthal
Impact of Hepatitis C Virus Infection on Children and Their Caregivers: Quality of Life, Cognitive, and Emotional Outcomes

Article • Journal of Pediatric Gastroenterology and Nutrition, March 2009, Wolters Kluwer Health

Dr Philip Rosenthal
Pediatric liver retransplantation: Outcomes and a prognostic scoring tool

Article • Liver Transplantation, February 2009, Wiley

Dr Philip Rosenthal
Caring for adults with pediatric liver disease

Article • Current Gastroenterology Reports, January 2009, Springer Science + Business Media

Dr Philip Rosenthal
Oral Disease Burden and Utilization of Dental Care Patterns Among Pediatric Solid Organ Transplant Recipients

Article • Journal of Public Health Dentistry, January 2009, Wiley

Dr Philip Rosenthal
Reply:

Article • Hepatology, August 2008, Wiley

Dr Philip Rosenthal
Fulminant hepatic failure in children

Article • Therapy, July 2008, Future Medicine

Dr Philip Rosenthal
Hepatocarcinoma in Viral and Metabolic Liver Disease

Article • Journal of Pediatric Gastroenterology and Nutrition, April 2008, Wolters Kluwer Health

Dr Philip Rosenthal
S1905 Lack of Correlation Between Diet Composition and Pediatric NAFLD Severity

Article • Gastroenterology, April 2008, Elsevier

Dr Philip Rosenthal
Pathology of chronic hepatitis C in children: Liver biopsy findings in the Peds-C Trial

Article • Hepatology, December 2007, Wiley

Dr Philip Rosenthal
Growth failure and outcomes in infants with biliary atresia: A report from the Biliary Atresia Research Consortium

Article • Hepatology, October 2007, Wiley

Dr Philip Rosenthal
Autoimmune hepatitis in children: diagnosis, pathology and treatment

Article • Expert Review of Clinical Immunology, March 2007, Taylor & Francis

Dr Philip Rosenthal
Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine

Article • Liver Transplantation, January 2007, Wiley

Dr Philip Rosenthal
A Mathematical Model of Hepatitis A Transmission in the United States Indicates Value of Universal Childhood Immunization

Article • Clinical Infectious Diseases, July 2006, Oxford University Press (OUP)

Dr Philip Rosenthal
The Comprehensive Assessment of Physical Fitness in Children Following Kidney and Liver Transplantation

Article • Transplantation, July 2006, Wolters Kluwer Health

Dr Philip Rosenthal
Propylthiouracil-associated liver failure presenting as probable autoimmune hepatitis in a child with Graves' disease

Article • Pediatric Transplantation, June 2006, Wiley

Dr Philip Rosenthal
The Physical Fitness of Pediatric Kidney and Liver Transplant Recipients

Article • Medicine & Science in Sports & Exercise, May 2006, Wolters Kluwer Health

Dr Philip Rosenthal
The Physical Fitness of Pediatric Kidney and Liver Transplant Recipients

Article • Medicine & Science in Sports & Exercise, May 2006, Wolters Kluwer Health

Dr Philip Rosenthal
Acute liver failure in children: The first 348 patients in the pediatric acute liver failure study group

Article • The Journal of Pediatrics, May 2006, Elsevier

Dr Philip Rosenthal, Dr. Linda S Hynan
A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000

Article • The Journal of Pediatrics, April 2006, Elsevier

Dr Philip Rosenthal
Trends over a decade of pediatric liver transplantation in the United States

Article • Liver Transplantation, January 2006, Wiley

Professor Sandy Feng, Dr Philip Rosenthal
Underdiagnosis of Pediatric Obesity and Underscreening for Fatty Liver Disease and Metabolic Syndrome by Pediatricians and Pediatric Subspecialists

Article • The Journal of Pediatrics, December 2005, Elsevier

Dr Philip Rosenthal
Current Options for Treatment of End-Stage Liver Disease in Children

Article • Current Pediatric Reviews, November 2005, Bentham Science Publishers

Dr Philip Rosenthal
Pediatric Gastroenterology Workforce Survey, 2003-2004

Article • Journal of Pediatric Gastroenterology and Nutrition, April 2005, Wolters Kluwer Health

Dr Philip Rosenthal
Hepatic Failure and Liver Transplant: Working Group Report of the Second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition

Article • Journal of Pediatric Gastroenterology and Nutrition, June 2004, Wolters Kluwer Health

Dr Philip Rosenthal
Prospective, Randomized, Multicenter, Controlled Trial of a Bioartificial Liver in Treating Acute Liver Failure

Article • Annals of Surgery, May 2004, Wolters Kluwer Health

Dr Philip Rosenthal
Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates

Article • Vaccine, March 2004, Elsevier

Dr Philip Rosenthal
Liver Failure, Pediatric

Article • January 2004, Elsevier

Dr Philip Rosenthal
The influence of portoenterostomy on transplantation for biliary atresia

Article • Liver Transplantation, January 2004, Wiley

Dr Philip Rosenthal
The seroprevalence of Helicobacter pylori in a referral population of children in the United States

Article • The American Journal of Gastroenterology, October 2003, Wolters Kluwer Health

Dr Philip Rosenthal
News and Views

Article • Journal of Pediatric Gastroenterology and Nutrition, July 2003, Wolters Kluwer Health

Dr Philip Rosenthal
Comparison of drainage techniques for biliary atresia

Article • Journal of Pediatric Surgery, July 2003, Elsevier

Dr Philip Rosenthal
Evidence of maternal microchimerism in livers of infants with biliary atresia

Article • Gastroenterology, April 2003, Elsevier

Dr Philip Rosenthal
Porphyria

Article • January 2003, Elsevier

Dr Philip Rosenthal
Hepatitis A: A Preventable Threat

Article • Journal of Pediatric Gastroenterology and Nutrition, November 2002, Wolters Kluwer Health

Dr Philip Rosenthal
Research Agenda for Pediatric Gastroenterology, Hepatology and Nutrition: Transplantation: Report of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition for the Children's Digestive Health and Nutrition Foundation

Article • Journal of Pediatric Gastroenterology and Nutrition, October 2002, Wolters Kluwer Health

Dr Philip Rosenthal
Allograft rejection in pediatric liver transplantation: Comparison between cadaveric and living related donors

Article • Pediatric Transplantation, September 2002, Wiley

Dr Philip Rosenthal
Donor Health Assessment After Living-Donor Liver Transplantation

Article • Annals of Surgery, July 2002, Wolters Kluwer Health

Dr Philip Rosenthal
Mushroom poisoning and auxiliary partial orthotopic liver transplantation

Article • The American Journal of Gastroenterology, May 2002, Wolters Kluwer Health

Dr Philip Rosenthal
CT and MRI of Hepatic Pseudotumor in Long-Standing Biliary Atresia

Article • Journal of Computer Assisted Tomography, May 2002, Wolters Kluwer Health

Dr Philip Rosenthal
ORTHOTOPIC LIVER TRANSPLANTATION FOR AUTOIMMUNE HEPATITIS AND CRYPTOGENIC CHRONIC HEPATITIS IN CHILDREN1

Article • Transplantation, September 2001, Wolters Kluwer Health

Dr Philip Rosenthal
Transjugular intrahepatic portosystemic shunt prior to renal transplantation in a child with autosomal-recessive polycystic kidney disease and portal hypertension: A case report

Article • Pediatric Transplantation, June 2001, Wiley

Dr Philip Rosenthal
Biliary strictures after pediatric liver transplantation: Clinical spectrum and outcome

Article • Gastroenterology, April 2001, Elsevier

Dr Philip Rosenthal
Auxiliary liver transplantation for toxic mushroom poisoning

Article • The Journal of Pediatrics, March 2001, Elsevier

Dr Philip Rosenthal
Medical Therapy of Brain Edema in Fulminant Hepatic Failure? Are We There Yet?

Article • Journal of Pediatric Gastroenterology and Nutrition, March 2001, Wolters Kluwer Health

Dr Philip Rosenthal
Fitness testing of pediatric liver transplant recipients

Article • Liver Transplantation, March 2001, Wiley

Dr Philip Rosenthal
Surgical Anatomy of the Left Lateral Segment as Applied to Living-Donor and Split-Liver Transplantation

Article • Annals of Surgery, November 2000, Wolters Kluwer Health

Dr Philip Rosenthal
The Time Is Right for the Use of Liver Dialysis Devices in Patients With Hepatorenal Syndrome

Article • Journal of Pediatric Gastroenterology and Nutrition, September 2000, Wolters Kluwer Health

Dr Philip Rosenthal
Is Interferon Therapy in Pediatric Chronic Hepatitis B Infection Warranted?

Article • Journal of Pediatric Gastroenterology and Nutrition, September 2000, Wolters Kluwer Health

Dr Philip Rosenthal
CURRENT STATUS OF PEDIATRIC LIVER TRANSPLANTATION

Article • Clinics in Liver Disease, August 2000, Elsevier

Dr Philip Rosenthal
Is Our Approach to Treating Chronic Hepatitis C All Wrong?

Article • Journal of Pediatric Gastroenterology and Nutrition, August 2000, Wolters Kluwer Health

Dr Philip Rosenthal
DONOR HEALTH ASSESSMENT FOLLOWING LIVING-DONOR LIVER TRANSPLANTATION.

Article • Transplantation, April 2000, Wolters Kluwer Health

Dr Philip Rosenthal
Eotaxin and Eosinophilic Homing to the Gut

Article • Journal of Pediatric Gastroenterology and Nutrition, March 2000, Wolters Kluwer Health

Dr Philip Rosenthal
The Efficacy of Cisapride; Time to Review Not Regurgitate

Article • Journal of Pediatric Gastroenterology and Nutrition, March 2000, Wolters Kluwer Health

Dr Philip Rosenthal
The Efficacy of Cisapride: What Is Needed for Digestion?

Article • Journal of Pediatric Gastroenterology and Nutrition, March 2000, Wolters Kluwer Health

Dr Philip Rosenthal
Emerging Role of the Enteric Nervous System in Mediating Host Responses to Microbial Infections

Article • Journal of Pediatric Gastroenterology and Nutrition, March 2000, Wolters Kluwer Health

Dr Philip Rosenthal
Authors' Reply

Article • Journal of Pediatric Gastroenterology and Nutrition, February 2000, Wolters Kluwer Health

Dr Philip Rosenthal
Is It Time for Separate Pediatric Hepatology and Liver Transplant Training Programs and Special Certification or Qualification?

Article • Journal of Pediatric Gastroenterology and Nutrition, February 2000, Wolters Kluwer Health

Dr Philip Rosenthal
Is there a future for liver-assist devices?

Article • Current Gastroenterology Reports, January 2000, Springer Science + Business Media

Dr Philip Rosenthal
Variable Morbidity in Alagille Syndrome: A Review of 43 Cases

Article • Journal of Pediatric Gastroenterology and Nutrition, October 1999, Wolters Kluwer Health

Dr Philip Rosenthal
Secretin: Cure or Snake Oil for Autism in the New Millennium?

Article • Journal of Pediatric Gastroenterology and Nutrition, August 1999, Wolters Kluwer Health

Dr Philip Rosenthal
GB Virus C (GBV-C/HGV) and E2 Antibodies in Children Preliver and Postliver Transplant

Article • Pediatric Research, June 1999, Springer Science + Business Media

Dr Philip Rosenthal
Living Related Donor Transplantation: The Future

Article • Journal of Pediatric Gastroenterology and Nutrition, May 1999, Wolters Kluwer Health

Dr Philip Rosenthal
Mycophenolate mofetil, microemulsion cyclosporine, and prednisone as primary immunosuppression for pediatric liver transplant recipients

Article • Liver Transplantation and Surgery, March 1999, Wiley

Dr Philip Rosenthal
Severe congenital anomalies requiring transplantation in children with Kabuki syndrome

Article • American Journal of Medical Genetics, December 1998, Wiley

Dr Philip Rosenthal
Severe congenital anomalies requiring transplantation in children with Kabuki syndrome

Article • American Journal of Medical Genetics, December 1998, Wiley

Dr Philip Rosenthal
Biliary complications of reduced-organ liver transplantation

Article • Liver Transplantation and Surgery, September 1998, Wiley

Dr Philip Rosenthal
Posttransplant lymphoproliferative disorder presenting in the head and neck

Article • The Laryngoscope, August 1998, Wiley

Dr Philip Rosenthal
Hepatitis A Vaccine: Current Indications

Article • Journal of Pediatric Gastroenterology and Nutrition, July 1998, Wolters Kluwer Health

Dr Philip Rosenthal
Interferon alfa therapy for chronic hepatitis B in children: A multinational randomized controlled trial☆

Article • Gastroenterology, May 1998, Elsevier

Dr Philip Rosenthal
Quality of Life of Adolescents Following Liver Transplant: The Perspectives of Parents and Recipients 557

Article • Pediatric Research, April 1998, Springer Science + Business Media

Dr Philip Rosenthal
Transjugular intrahepatic portosystemic shunts (TIPS) in children

Article • The Journal of Pediatrics, December 1997, Elsevier

Dr Philip Rosenthal
IMPORTANCE OF EMPOWERING PEDIATRICIANS IN THE OUTPATIENT CARE OF CHILDREN WITH LIVER TRANSPLANTS. † 492

Article • Pediatric Research, April 1997, Springer Science + Business Media

Dr Philip Rosenthal
Chronic Hepatitis C Viral Infection In Childhood: To Treat or Not To Treat with Interferon-That Is The Question

Article • Journal of Pediatric Gastroenterology and Nutrition, March 1997, Wolters Kluwer Health

Dr Philip Rosenthal
Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity

Article • The Journal of Pediatrics, February 1997, Elsevier

Dr Philip Rosenthal
Report from the NASPGN Therapeutics Subcommittee

Article • Journal of Pediatric Gastroenterology and Nutrition, November 1996, Wolters Kluwer Health

Dr Philip Rosenthal
Functional Analysis of Grafts from Living Donors

Article • Annals of Surgery, October 1996, Wolters Kluwer Health

Dr Philip Rosenthal
LIVING-RELATED LIVER TRANSPLANTS FOR ADULTS? THE TIME HAS COME!

Article • Journal of Pediatric Gastroenterology and Nutrition, October 1996, Wolters Kluwer Health

Dr Philip Rosenthal
FAILURE PATTERNS OF CRYOPRESERVED VEIN GRAFTS IN LIVER TRANSPLANTATION1,2

Article • Transplantation, September 1996, Wolters Kluwer Health

Dr Philip Rosenthal
LIVER DISEASE IN POLYGLANDULAR AUTOIMMUNE DISEASE TYPE ONE: Clinicopathologic Study of Three Patients and Review of the Literature

Article • Pediatric Pathology & Laboratory Medicine, August 1996, Taylor & Francis

Dr Philip Rosenthal
Liver Disease in Polyglandular Autoimmune Disease Type One: Clinicopathologic Study of Three Patients and Review of the Literature

Article • Fetal and Pediatric Pathology, July 1996, Informa Healthcare

Dr Philip Rosenthal
The role of whole organ pancreas transplantation in the treatment of type I diabetes

Article • The American Journal of Surgery, May 1996, Elsevier

Dr Philip Rosenthal
Liver Disease in Polyglandular Autoimmune Disease Type One: Clinicopathologic Study of Three Patients and Review of the Literature

Article • Pediatric Pathology & Laboratory Medicine, January 1996, Taylor & Francis

Dr Philip Rosenthal
Hepatitis B virus serology in pregnant women

Article • The Pediatric Infectious Disease Journal, November 1995, Wolters Kluwer Health

Dr Philip Rosenthal
Failure of liver transplantation to diminish cardiac deposits of amylopectin and leukocyte inclusions in type iv glycogen storage disease

Article • Liver Transplantation and Surgery, November 1995, Wiley

Dr Philip Rosenthal
Portal hypertension in children

Article • Current Opinion in Pediatrics, October 1995, Wolters Kluwer Health

Dr Philip Rosenthal
Critical care in pediatric liver transplantation

Article • Clinical Biochemistry, June 1995, Elsevier

Dr Philip Rosenthal
Conjugated hyperbilirubinemia in a newborn infant after maternal (transplacental) treatment with flecainide acetate for fetal tachycardia and fetal hydrops

Article • The Journal of Pediatrics, June 1995, Elsevier

Dr Philip Rosenthal
Neonatal Dubin-Johnson Syndrome

Article • Journal of Pediatric Gastroenterology and Nutrition, August 1994, Wolters Kluwer Health

Dr Philip Rosenthal
Medical Therapies for Pediatric Gastrointestinal Disease

Article • Journal of Pediatric Gastroenterology and Nutrition, April 1994, Wolters Kluwer Health

Dr Philip Rosenthal
Comparison of arterial and capillary bilirubin values in neonates with arterial lines

Article • The Journal of Pediatrics, November 1993, Elsevier

Dr Philip Rosenthal
Case Report Hepatic Pseudomass on Ultrasound in Children with Fatty Infiltration of the Liver

Article • Journal of Pediatric Gastroenterology and Nutrition, February 1993, Wolters Kluwer Health

Dr Philip Rosenthal
Successful Late Kasai Portoenterostomy

Article • Journal of Pediatric Gastroenterology and Nutrition, February 1992, Wolters Kluwer Health

Dr Philip Rosenthal
False-positive results of tests for hepatitis C in autoimmune hepatitis

Article • The Journal of Pediatrics, January 1992, Elsevier

Dr Philip Rosenthal
Immunogenicity of Haemophilus influenzae Type B Vaccines in Children with Hepatoportoenterostomies

Article • Journal of Pediatric Gastroenterology and Nutrition, August 1990, Wolters Kluwer Health

Dr Philip Rosenthal
Atropine Therapy and Paralytic Ileus in an Infant

Article • Journal of Pediatric Gastroenterology and Nutrition, November 1989, Wolters Kluwer Health

Dr Philip Rosenthal
Hepatobiliary Scintigraphy and the String Test in the Evaluation of Neonatal Cholestasis

Article • Journal of Pediatric Gastroenterology and Nutrition, April 1989, Wolters Kluwer Health

Dr Philip Rosenthal
The BUN/Creatinine Ratio in Localizing Gastrointestinal Bleeding in Pediatric Patients

Article • Journal of Pediatric Gastroenterology and Nutrition, September 1988, Wolters Kluwer Health

Dr Philip Rosenthal
Bilirubin Subfractions-Reply

Article • Archives of Pediatrics and Adolescent Medicine, July 1988, American Medical Association (AMA)

Dr Philip Rosenthal
CERULETIDE TO TREAT NEONATAL CHOLESTASIS

Article • The Lancet, May 1988, Elsevier

Dr Philip Rosenthal
The Effect of Tin-Protoporphyrin on Bilirubin Conjugation and Production in Cholestatic Rats

Article • Pediatric Research, February 1988, Springer Science + Business Media

Dr Philip Rosenthal
Correlation of carbon monoxide and bilirubin production by tissue homogenates

Article • Journal of Chromatography B Biomedical Sciences and Applications, January 1988, Elsevier

Dr Philip Rosenthal
SERUM BILIRUBIN FRACTIONS IN CHOLESTATIC RATS TREATED WITH TIN PROTOPORPHYRIN

Article • Pediatric Research, April 1987, Springer Science + Business Media

Dr Philip Rosenthal
Distribution of serum bilirubin conjugates in pediatric hepatobiliary diseases

Article • The Journal of Pediatrics, February 1987, Elsevier

Dr Philip Rosenthal
Orthotopic liver transplantation for type I Crigler-Najjar syndrome

Article • Hepatology, November 1986, Wiley

Dr Philip Rosenthal
Formation of Bilirubin Conjugates in Human Newborns

Article • Pediatric Research, October 1986, Springer Science + Business Media

Dr Philip Rosenthal
Diseases of the Liver and Biliary System

Article • Journal of Pediatric Gastroenterology and Nutrition, July 1986, Wolters Kluwer Health

Dr Philip Rosenthal
Long-Term External Catheter Biliary Drainage for Recurrent Cholangitis After Hepatoportoenterostomy

Article • Journal of Pediatric Gastroenterology and Nutrition, May 1986, Wolters Kluwer Health

Dr Philip Rosenthal
Management of children with hyperbilirubinemia and green teeth

Article • The Journal of Pediatrics, January 1986, Elsevier

Dr Philip Rosenthal
Long

Article • Journal of Pediatric Gastroenterology and Nutrition, August 1985, Wolters Kluwer Health

Dr Philip Rosenthal
Nutrition and Feeding of Infants and Toddlers

Article • Journal of Pediatric Gastroenterology and Nutrition, August 1985, Wolters Kluwer Health

Dr Philip Rosenthal
Nutrition and Feeding of Infants and Toddlers

Article • Journal of Pediatric Gastroenterology and Nutrition, August 1985, Wolters Kluwer Health

Dr Philip Rosenthal
String test in evaluation of cholestatic jaundice in infancy

Article • The Journal of Pediatrics, August 1985, Elsevier

Dr Philip Rosenthal
Collection of Duodenal Bile in Infants and Children by the String Test

Article • Journal of Pediatric Gastroenterology and Nutrition, April 1985, Wolters Kluwer Health

Dr Philip Rosenthal
Practical Paediatric Gastroenterology

Article • Archives of Pediatrics and Adolescent Medicine, July 1984, American Medical Association (AMA)

Dr Philip Rosenthal
Detection of Occult Blood in Gastric Juice

Article • Journal of Clinical Gastroenterology, April 1984, Wolters Kluwer Health

Dr Philip Rosenthal
Hydrolysis of lactose in milk

Article • The Journal of Pediatrics, August 1983, Elsevier

Dr Philip Rosenthal
Ultrastructural abnormalities of the liver in total lipodystrophy

Article • Human Pathology, September 1981, Elsevier

Dr Philip Rosenthal
226 DEVELOPMENT OF BILIRUBIN CONJUGATION IN HUMAN NEW-BORNS

Article • Pediatric Research, April 1981, Springer Science + Business Media

Dr Philip Rosenthal
Infantile Cholestatic Liver Disease-Reply

Article • Archives of Pediatrics and Adolescent Medicine, August 1980, American Medical Association (AMA)

Dr Philip Rosenthal
Cholelithiasis in a 2-year-old child with reflux esophagitis and hiatus hernia

Article • The Journal of Pediatrics, May 1980, Elsevier

Dr Philip Rosenthal
Comparative study of stool examinations, duodenal aspiration, and pediatric Entero-Test for giardiasis in children

Article • The Journal of Pediatrics, February 1980, Elsevier

Dr Philip Rosenthal
Alpha1-antitrypsin Deficiency and Severe Infantile Liver Disease

Article • Archives of Pediatrics and Adolescent Medicine, November 1979, American Medical Association (AMA)

Dr Philip Rosenthal
Neonatal hyperammonemia

Article • The Journal of Pediatrics, May 1979, Elsevier

Dr Philip Rosenthal
Neonatal Hepatitis and Congenital Infections

Article • Cambridge University Press

Dr Philip Rosenthal
Neonatal hepatitis and congenital infections

Article • Cambridge University Press

Dr Philip Rosenthal
Hepatitis A and hepatitis E virus infection

Article • Cambridge University Press

Dr Philip Rosenthal

Search

Main menu

Discover

Subjects on Kudos

Services and resources

Admin

All Stories